Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice

Mohammad Ali Danesh-Bahreini1 Department of Pharmaceutics;5 Research and Development Department, Exir Pharmaceutical Company, Borujerd, Iran

Javad Shokri1 Department of Pharmaceutics;2 Research Center for Pharmaceutical Nanotechnology, School of Pharmacy, Tabriz University of Medical Science, Tabriz, Iran

Afshin Samiei3 Autoimmune Diseases Research Center, School of Medicine

Eskandar Kamali-Sarvestani4 Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Science, Shiraz, Iran

Mohammad Barzegar-Jalali1 Department of Pharmaceutics

Soliman Mohammadi-Samani4 Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Science, Shiraz, IranCorrespondence[email protected]

Pages 835-842 | Published online: 20 Apr 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SoongLModulation of dendritic cell function by leishmania parasitesJ Immunol20081804355436018354154
PubMed Web of Science ®Google Scholar
El-OnJCurrent status and perspectives of the immunotherapy of leishmaniasisIsr Med Assoc J20091162362720077951
PubMed Web of Science ®Google Scholar
World Health OrganizationLeishmaniasis. The disease and its epidemiology Available at: www.who.int/leishmaniasis.disease_epidemiology/en/index.html. Accessed on January 25, 2011.
Google Scholar
DaherEFFonsecaPPGerhardESLeitaoTMSilva JuniorGBClinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from BrazilJ Parasitol20099565265519642802
PubMed Web of Science ®Google Scholar
MarrJNilsenTKomunieckiRMolecular Medical ParasitologySan Diego, CAAcademic Press2003
Google Scholar
OkworIUzonnaJVaccines and vaccination strategies against human cutaneous leishmaniasisHum Vaccin2009529130119221514
PubMed Web of Science ®Google Scholar
SharifiIFeKriARAflatonianMRRandomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, IranLancet19983511540154310326536
PubMed Web of Science ®Google Scholar
Palatnik-de-SousaCBVaccines for leishmaniasis in the fore coming 25 yearsVaccine2008261709172418295939
PubMed Web of Science ®Google Scholar
SpitzerNJardimALippertDOlafsonRWLong-term protection of mice against Leishmania major with a synthetic peptide vaccineVaccine1999171298130010195763
PubMed Web of Science ®Google Scholar
YeganehFBarkhordariFOmidiMCloning and expression of Leishmania major superoxide dismutase B1: A potential target antigen for serodiagnosis of LeishmaniasisIran J Immunol2009613014019801786
PubMedGoogle Scholar
DufernezFYernauxCGerbodDThe presence of four iron-containing superoxide dismutase isozymes in trypanosomatidae: Characterization, subcellular localization, and phylogenetic origin in Trypanosoma bruceiFree Radic Biol Med20064021022516413404
PubMed Web of Science ®Google Scholar
GhoshSGoswamiSAdhyaSRole of superoxide dismutase in survival of Leishmania within the macrophageBiochem J.2003369Pt 344745212459037
PubMed Web of Science ®Google Scholar
HandmanELeishmaniasis: Current status of vaccine developmentClin Microbiol Rev20011422924311292637
PubMed Web of Science ®Google Scholar
KensilCRMoAXTrunehACurrent vaccine adjuvants: An overview of a diverse classFront Biosci200492972298815353330
PubMed Web of Science ®Google Scholar
ShahidiFAbuzaytounRChitin, chitosan, and co-products: Chemistry, production, applications, and health effectsAdv Food Nutr Res2005499313515797344
PubMedGoogle Scholar
BodmeierRChenHGPaeratakulOA novel approach to the oral delivery of micro- or nanoparticlesPharm Res198964134172748533
PubMed Web of Science ®Google Scholar
CalvoPRemunan-LopezCVila-JatoJLAlonsoMJChitosan and chitosan/ethylene oxide-propylene oxide block copolymer nano-particles as novel carriers for proteins and vaccinesPharm Res199714143114369358557
PubMed Web of Science ®Google Scholar
VilaASanchezAJanesKLow molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in miceEur J Pharm Biopharm20045712313114729088
PubMed Web of Science ®Google Scholar
GanQWangTChitosan nanoparticle as protein delivery carrier – systematic examination of fabrication conditions for efficient loading and releaseColloids Surf B Biointerfaces200759243417555948
PubMed Web of Science ®Google Scholar
AktasYAndrieuxKAlonsoMJPreparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitorInt J Pharm200529837838315893439
PubMed Web of Science ®Google Scholar
ZhuBQieYWangJChitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosisEur J Pharm Biopharm20076631832617280823
PubMed Web of Science ®Google Scholar
ZaharoffDARogersCJHanceKWSchlomJGreinerJWChitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccinationVaccine2007252085209417258843
PubMed Web of Science ®Google Scholar
HoffJMethods of blood collection in the mouseLab Anim2000294753
Web of Science ®Google Scholar
TsaiMLBaiSWChenRHCavitation effects versus stretch effects resulted in different size and polydispersity of ionotropic gelation chitosan-sodium tripolyphosphate nanoparticleCarbohydr Polym2007714481457
Web of Science ®Google Scholar
JanesKACalvoPAlonsoMJPolysaccharide colloidal particles as delivery systems for macromoleculesAdv Drug Deliv Rev200147839711251247
PubMed Web of Science ®Google Scholar
ZahrASDavisCAPishkoMVMacrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol)Langmuir2006228178818516952259
PubMed Web of Science ®Google Scholar
MurrayHWBermanJDDaviesCRSaraviaNGAdvances in leishmaniasisLancet20053661561157716257344
PubMed Web of Science ®Google Scholar
AbbasAKLichtmanAHCellular and Molecular Immunology5th edPhiladelphia, PASaunders Co2003
Google Scholar
DayMJImmunoglobulin G subclass distribution in canine leishmaniasis: A review and analysis of pitfalls in interpretationVet Parasitol20071472817467176
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date